Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

The effects of atherogenic particles and omega-3 fatty acids on the risk factors for type 2 diabetes

FY 2013-14

Summary
Almost 2 million Canadians have type 2 diabetes (T2D). Although obesity increases the risk of T2D, only about 15 – 20 % of obese subjects become diabetic. All obese subjects are not at equal risk of T2D. Rather it is a subgroup of subjects in whom obesity is coupled to insulin resistance (IR) that are at a higher risk. IR is a physiological state in which the cells of the body fail to properly respond to the hormone insulin that increases the utilization of sugars (i.e. glucose). A major abnormality implicated in IR is the presence of a chronic inflammatory state, particularly in some tissues like fat tissue, without the presence of an infectious agent. This condition decreases the action of insulin (i.e. IR) and in the liver; this also promotes the secretion of higher numbers of atherogenic lipoproteins (apoB). Lipoproteins are the particles responsible for the transport of lipids like fat and cholesterol in the circulation. Interestingly, recent data suggest that elevated apoB may be a promoter and not only a consequence of IR and T2D and that is through activation of the interleukin-1í (IL-1í) system. IL-1í is a master regulator of inflammation that is implicated in the pathogenesis of dysfunctional fat tissue and the development of diabetes10,11. The production of IL-1í is regulated by an intracellular receptor termed “the NLRP3 inflammasome” whose activation requires 2 signals. Recent data generated in our lab suggest that apoB promote fat tissue NLRP3 activation, an effect that can be counterbalanced by omega-3 fatty acids. We thus propose to investigate the mechanisms by which apoB and omega-3 fatty acids can activate the NLRP3 inflammasome in human immune cells (macrophages) and fat cells (adipocytes), which are represent the primary cell populations of adipose tissue.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
312030
Name
Cyr Yannick
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The effects of atherogenic particles and omega-3 fatty acids on the risk factors for type 2 diabetes
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apob-Lipoproteins; Interleukin-1 Beta; Nlrp3 Inflammasome; Obesity; Omega-3 Fatty Acid; Type 2 Diabetes
Abstract
Almost 2 million Canadians have type 2 diabetes (T2D). Although obesity increases the risk of T2D, only about 15 – 20 % of obese subjects become diabetic. All obese subjects are not at equal risk of T2D. Rather it is a subgroup of subjects in whom obesity is coupled to insulin resistance (IR) that are at a higher risk. IR is a physiological state in which the cells of the body fail to properly respond to the hormone insulin that increases the utilization of sugars (i.e. glucose). A major abnormality implicated in IR is the presence of a chronic inflammatory state, particularly in some tissues like fat tissue, without the presence of an infectious agent. This condition decreases the action of insulin (i.e. IR) and in the liver; this also promotes the secretion of higher numbers of atherogenic lipoproteins (apoB). Lipoproteins are the particles responsible for the transport of lipids like fat and cholesterol in the circulation. Interestingly, recent data suggest that elevated apoB may be a promoter and not only a consequence of IR and T2D and that is through activation of the interleukin-1í (IL-1í) system. IL-1í is a master regulator of inflammation that is implicated in the pathogenesis of dysfunctional fat tissue and the development of diabetes10,11. The production of IL-1í is regulated by an intracellular receptor termed “the NLRP3 inflammasome” whose activation requires 2 signals. Recent data generated in our lab suggest that apoB promote fat tissue NLRP3 activation, an effect that can be counterbalanced by omega-3 fatty acids. We thus propose to investigate the mechanisms by which apoB and omega-3 fatty acids can activate the NLRP3 inflammasome in human immune cells (macrophages) and fat cells (adipocytes), which are represent the primary cell populations of adipose tissue.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cyr, Yannick
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~